Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".
Bram L T RamaekersRob RiemsmaFlorian TominiThea van AsseltSohan DeshpandeSteven DuffyNigel ArmstrongJohan L SeverensJos KleijnenManuela A JoorePublished in: PharmacoEconomics (2019)